Primary Staph Aureus Bacteremia Indication Problematic For Most Cmte. Members
This article was originally published in The Pink Sheet Daily
FDA's Anti-Infectives Drugs Advisory Committee recommends dividing S. aureus bacteremia into complicated and uncomplicated infections. Committee also suggests changes to guidance on catheter-related blood stream infections.
You may also be interested in...
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.
The U.K.’s Health and Social Care Bill was introduced into Parliament on Jan. 19, offering a new commercial landscape best navigated by pharma through bolstered relationships with general practitioners.
FDA’s proposal for relabeling of antihypertensive agents is based on prior recommendations by the committee that information on cardiovascular outcomes related to blood pressure lowering be included as class labeling.